Acadian Asset Management’s Vir Biotechnology VIR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-52,193
| Closed | -$335K | – | 1846 |
|
|
2025
Q1 | $335K | Buy |
+52,193
| New | +$335K | ﹤0.01% | 1159 |
|
|
2024
Q1 | – | Sell |
-2,692
| Closed | -$27K | – | 1798 |
|
|
2023
Q4 | $27K | Sell |
2,692
-144,381
| -98% | -$1.45M | ﹤0.01% | 1556 |
|
|
2023
Q3 | $1.38M | Sell |
147,073
-17,410
| -11% | -$163K | 0.01% | 783 |
|
|
2023
Q2 | $4.03M | Sell |
164,483
-11,713
| -7% | -$287K | 0.02% | 507 |
|
|
2023
Q1 | $4.1M | Buy |
176,196
+67,103
| +62% | +$1.56M | 0.02% | 510 |
|
|
2022
Q4 | $2.76M | Sell |
109,093
-90,324
| -45% | -$2.29M | 0.01% | 596 |
|
|
2022
Q3 | $3.84M | Buy |
199,417
+56,168
| +39% | +$1.08M | 0.02% | 477 |
|
|
2022
Q2 | $3.65M | Buy |
143,249
+135,531
| +1,756% | +$3.45M | 0.02% | 486 |
|
|
2022
Q1 | $197K | Buy |
+7,718
| New | +$197K | ﹤0.01% | 1217 |
|
|
2021
Q4 | – | Sell |
-4,655
| Closed | -$200K | – | 1863 |
|
|
2021
Q3 | $200K | Buy |
+4,655
| New | +$200K | ﹤0.01% | 1296 |
|